George Georgiou, Prof. of Chemical Engineering at the University of Texas at Austin, USA & Founder of Aeglea Biotherapeutics  and Kyn Therapeutics Inc. (now Ikena Oncology) visited BSRC Fleming on Friday, June 23rd, 2023. Prof. Georgiou presented a scientific seminar entitled “New Facets of Humoral Immunity: The Serological Antibody Repertoire in Health and Disease”. He then discussed with BSRC Fleming PIs and junior researchers the implications for bioinnovation, which stem from our improved knowledge of the repertoire of the antibodies produced by the human immune system. Prof. Georgiou described his scientific journey as part of an interview to our Science Communication Manager, Dr. Vasiliki Michopoulou. You can find the complete interview here: